Skip to Content

Tag: stock


Vendors

Invacare, Hill-Rom see stock movement

September 13, 2016HME News Staff

ELYRIA, Ohio - Invacare recently lost one investor, but gained two.Linden Advisors sold all of its stake in Invacare during the most recent quarter, according to a disclosure report filed with the Securities and Exchange Commission. It sold 48,554 shares of company stock valued at $604,497. Other hedge funds, including Gotham Asset Management, have sold their stakes in Invacare during the most recent quarter.On the flip side, Alphaone Investment Services bought 54,253 additional shares of Invacare...

Hill-Rom, Invacare, investment, stock


Read Full Articlered right arrow icon

Also Noted

Stock movers: Invacare and ResMed

May 12, 2016HME News Staff

Heartland Advisors has picked up 88,747 additional shares of Invacare stock, the firm disclosed in a report filed with the SEC on May 3. Heartland Advisors now holds about 3.6 million shares valued at about $39.95 million. Invacare now makes up about 2.09% of its portfolioÖPeter Farrell, a director at ResMed, sold 20,000 shares of the company's stock at an average price of $55.90 in a transaction on May 4 valued at about $1.12 million. He now owns 367,978 shares valued at about $20.6 million.

hedge fund, Invacare, ResMed, stock


Read Full Articlered right arrow icon

Also Noted

Stock movers: Ray Huggenberger, Mick Farrell

April 22, 2016HME News Staff

Inogen CEO Ray Huggenberger sold more than half of his shares in the company in a transaction April 15. He sold 29,635 shares at an average price of $48.59 for a total value of $1.44 million. He now owns 25,210 sharesÖResMed CEO Mick Farrell sold 5,975 shares at an average price of $59.34 in a transaction on April 15 valued at $354,556. He now owns 154,723 shares.

Inogen, ResMed, stock


Also Noted

ResMed's Farrell sells $1M in shares

January 8, 2016HME News Staff

SAN DIEGO - Peter Farrell, founder and chairman of ResMed, sold 20,000 shares of company stock valued at $1.04 million in a transaction on Jan. 4. Farrell still owns 347,978 shares in the company, valued at $18.2 million. On that same day, David Pendarvis, chief administrative officer and global general counsel, sold 6,000 shares valued at $312,960. He still owns 74,287 shares.

ResMed, stock


Also Noted

Inogen shareholders sell

December 30, 2014HME News Staff

GOLETA, Calif. - Two Inogen shareholders have moved stock this month. Scott Wilkinson sold 15,735 shares on Dec. 29 at an average price of $30.52 per share for a total transaction of $480,232. Versant Ventures sold 9,785 shares on Dec. 23 at an average price of $29.74 for a total transaction of $291,005. Versant Ventures is a majority shareholder in the company, owning at least 10% of its shares.

Inogen, public company, shareholders, stock


Also Noted

Inogen exec sells additional shares

September 23, 2014HME News Staff

NEW YORK - Inogen Director Timothy Petersen sold 46,865 shares on Sept. 22 in a transaction worth nearly $1 million. The shares sold at an average price of $21.05 for a total of $986,508. Peterson previously sold 39,135 shares on Sept. 17 in a transaction worth $850,012.

Inogen, sale, stock


Also Noted

Inogen execs sell shares

September 18, 2014HME News Staff

NEW YORK - Two Inogen executives sold off some of their company stock this week. Vice President Byron Myers sold 22,333 shares Sept. 15 at an average price of $21.33 for a total transaction of $476,362. Director Timothy Peterson sold 39,135 shares Sept. 17 at an average price of $21.72 for a total value of $850,012.

Inogen, stock


Also Noted

Farrell unloads ResMed stock

May 6, 2014HME News Staff

SAN DIEGO - Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million. Farrell still owns 304,990 shares in the company valued at $15.188 million. The sale was disclosed in a document filed with the Securities & Exchange Commission.

Peter Farrell, ResMed, stock


Also Noted

INGN opens for trading

February 18, 2014HME News Staff

GOLETA, Calif. - Inogen (INGN) opened for trading on the NASDAQ on Feb. 14, pricing about 4.4 million shares of its stock at $16 per share, the low end of an expected range of $16 to $18. On Feb. 18, the company's stock was trading at $15.28 per share. Inogen filed for an initial public offering (IPO) in November. J.P. Morgan was the sole bookrunner on the deal.

Inogen, Nasdaq, stock


Also Noted

Invacare board member sells shares

December 13, 2013HME News Staff

ELYRIA, Ohio - C. Martin Harris, a member of the board of directors of Invacare, sold 1,775 shares of company stock Dec. 9, according to new reports. Harris sold the shares for, on average, $22.15 each, for a total of $39,316. Harris, who is the chief information officer and chairman of the Information Technology Division at the Cleveland Clinic Foundation, now owns 16,806 shares of Invacare stock, worth about $372,253.

C. Martin Harris, Invacare, stock